Found 27 matching trials
Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation
PHASE1The recent introduction of ex-vivo lung perfusion (EVLP) as a tool to evalu...
Location
Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
PHASE1The purpose of this study is to assess the safety and tolerability of VBI-1...
Location
University of California, Irvine
Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System⢠at a Dedicated EVLP Facility
NAThis is a safety study to compare the safety of receiving a lung treated wi...
Location
Mayo Clinic Jacksonville
BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction
EARLY_PHASE1This study will determine if primary graft dysfunction (which causes low bl...
Location
Northwestern University
Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial
PHASE1Post-transplant lymphoproliferative disorders (PTLD) can present as a type ...
Location
University Health Network, Toronto General Hospital, Multi-Organ Transplant
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
NAHuman donor lungs that do not meet the standard clinical criteria for donor...
Location
Cedars-Sinai Medical Center
EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs
PHASE1The procurement of organs from donors after cardiocirculatory death (DCD) i...
Location
Fondazione IRCCS a' Granda - Ospedale Maggiore Policlinico
Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation
PHASE1The use of ex vivo lung perfusion (EVLP) will allow for a secondary evaluat...
Location
Toronto General Hospital
The University of Alberta Negative Pressure Ventilation Ex-Vivo Lung Perfusion (NPV-EVLP) Trial
NAThis project is focused on helping one of the most vulnerable patient popul...
Location
University of Alberta Hospital
Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System
EARLY_PHASE1The purpose of this study is to see if adding a drug called Regadenoson to ...
Location
University of Maryland Medical Center